Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Isr J Psychiatry Relat Sci ; 46(1): 70-3, 2009.
Artigo em Inglês | MEDLINE | ID: mdl-19728575

RESUMO

Narcolepsy is characterized by symptoms that include excessive sleepiness during the daytime, cataplexy, hypnagogic hallucinations and sleep paralysis. We present a single unusual case report of a patient who was admitted to a psychiatric facility. A 20-year-old single woman was hospitalized in a general hospital due to involuntary movements in her limbs. Following complaints of continual daily sleepiness and instances of a loss of muscle tone she was referred for sleep assessment. The patient was diagnosed with narcolepsy and cataplexy. Later, due to auditory hallucinations she was referred to a psychiatric hospital. Her reality judgement was poor, with partial insight regarding her illness. The patient was treated with methylphenidate 20 mg/day and antipsychotic medication; risperidone of up to 4 mg/day, and paroxetine 20 mg/day to prevent cataplexy. Following further exacerbation, pharmacotherapy was changed to risperidone 6 mg/day and modafinil 200 mg/day. This treatment led to a significant improvement in her condition. The report presented here suggests that combined treatment with a psycho-stimulant drug, an SSRI in combination with antipsychotic treatment, may be indicated in narcolepsy with cataplexy and vivid psychotic production. Multidisciplinary cooperation of neurologists and psychiatrists enabled this therapy to be administered for the patient's benefit.


Assuntos
Cataplexia/diagnóstico , Alucinações/diagnóstico , Narcolepsia/diagnóstico , Transtornos Psicóticos/diagnóstico , Antipsicóticos/uso terapêutico , Compostos Benzidrílicos/uso terapêutico , Cataplexia/tratamento farmacológico , Estimulantes do Sistema Nervoso Central/uso terapêutico , Comorbidade , Quimioterapia Combinada , Feminino , Alucinações/tratamento farmacológico , Hospitalização , Humanos , Modafinila , Narcolepsia/tratamento farmacológico , Paroxetina/uso terapêutico , Transtornos Psicóticos/tratamento farmacológico , Encaminhamento e Consulta , Risperidona/uso terapêutico , Inibidores Seletivos de Recaptação de Serotonina/uso terapêutico , Paralisia do Sono/diagnóstico , Paralisia do Sono/tratamento farmacológico , Adulto Jovem
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA